Bhutan vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Immunization, Hib3
Immunization, Hib3 over time
- Bhutan
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
How they compare
Bhutan currently reports 98.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 14.3%.
That makes Bhutan's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
Across all 13 years both countries report, Bhutan has been ahead every year.
Bhutan ranks 20th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 21st of 191 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.8% | 73.1% | 24.6% | Bhutan |
| 2020s | 97.8% | 82.5% | 15.3% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Bhutan or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Bhutan, at 98.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
- What is the difference in immunization, hib3 between Bhutan and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- 14.3%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- 13 years are reported by both, from 2012 to 2024.
- How do Bhutan and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for immunization, hib3?
- Bhutan ranks 20th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 21st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.